1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Infectious Disease Diagnostic Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
6.4. Software & Services

7. Infectious Disease Diagnostic Market, by Technology
7.1. Introduction
7.2. Biochemical Technology
7.3. Conventional Technology
7.4. Molecular Technology

8. Infectious Disease Diagnostic Market, by Application
8.1. Introduction
8.2. Bacterial Infection
8.3. Cardiovascular Infection
8.4. CNS Infection
8.5. Fungal Infection
8.6. Sexually Transmitted Disease
8.7. Viral Infection

9. Infectious Disease Diagnostic Market, by End User
9.1. Introduction
9.2. Hospital
9.3. Research Institutes

10. California Infectious Disease Diagnostic Market
10.1. Introduction

11. Florida Infectious Disease Diagnostic Market
11.1. Introduction

12. Illinois Infectious Disease Diagnostic Market
12.1. Introduction

13. New York Infectious Disease Diagnostic Market
13.1. Introduction

14. Ohio Infectious Disease Diagnostic Market
14.1. Introduction

15. Pennsylvania Infectious Disease Diagnostic Market
15.1. Introduction

16. Texas Infectious Disease Diagnostic Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories
18.1.1. Business Overview
18.1.2. Key Executives
18.1.3. Product & Services
18.2. Becton, Dickinson and Company
18.2.1. Business Overview
18.2.2. Key Executives
18.2.3. Product & Services
18.3. Bio-Rad Laboratories ,Inc
18.3.1. Business Overview
18.3.2. Key Executives
18.3.3. Product & Services
18.4. BioFire Diagnostics
18.4.1. Business Overview
18.4.2. Key Executives
18.4.3. Product & Services
18.5. Biomérieux SA
18.5.1. Business Overview
18.5.2. Key Executives
18.5.3. Product & Services
18.6. Co-Diagnostics, Inc.
18.6.1. Business Overview
18.6.2. Key Executives
18.6.3. Product & Services
18.7. Danaher Corporation
18.7.1. Business Overview
18.7.2. Key Executives
18.7.3. Product & Services
18.8. DiaSorin
18.8.1. Business Overview
18.8.2. Key Executives
18.8.3. Product & Services
18.9. HiberGene Diagnostics Limited
18.9.1. Business Overview
18.9.2. Key Executives
18.9.3. Product & Services
18.10. Luminex Corporation
18.10.1. Business Overview
18.10.2. Key Executives
18.10.3. Product & Services
18.11. Meridian Bioscience Inc.
18.11.1. Business Overview
18.11.2. Key Executives
18.11.3. Product & Services
18.12. Quidel Corporation
18.12.1. Business Overview
18.12.2. Key Executives
18.12.3. Product & Services
18.13. Roche Holding AG
18.13.1. Business Overview
18.13.2. Key Executives
18.13.3. Product & Services
18.14. Siemens AG
18.14.1. Business Overview
18.14.2. Key Executives
18.14.3. Product & Services
18.15. Thermo Fisher Scientific
18.15.1. Business Overview
18.15.2. Key Executives
18.15.3. Product & Services

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
FIGURE 8. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 11. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 15. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2027
FIGURE 17. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 23. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 30. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 32. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 34. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 42. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 43. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

List of Tables

TABLE 1. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 39. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 40. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 41. CALIFORNIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 42. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 44. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 45. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 46. FLORIDA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 47. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 49. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 50. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 51. ILLINOIS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 52. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 54. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 55. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 56. NEW YORK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 57. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 58. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 59. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 60. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 61. OHIO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 62. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 64. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 65. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 66. PENNSYLVANIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 67. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 68. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 69. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 70. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 71. TEXAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 73. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 74. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 75. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET RANKING, BY KEY PLAYER, 2021
TABLE 76. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2021
TABLE 77. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET MERGER & ACQUISITION
TABLE 78. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET INVESTMENT & FUNDING
TABLE 81. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 82. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Becton, Dickinson and Company
Bio-Rad Laboratories ,Inc
BioFire Diagnostics
Biomérieux SA
Co-Diagnostics, Inc.
Danaher Corporation
DiaSorin
HiberGene Diagnostics Limited
Luminex Corporation
Meridian Bioscience Inc.
Quidel Corporation
Roche Holding AG
Siemens AG
Thermo Fisher Scientific